NCT01404156 2024-08-28
POWERRANGER
CancerCare Manitoba
Phase 2/3 Completed
Clinical Trials
11 trialsNCT02746796 2024-05-03
Study of ONO-4538 in Gastric Cancer
Ono Pharmaceutical Co. Ltd
Phase 2/3 Completed
NCT03607656 2023-12-18
CHANGE
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Completed
NCT01962246 2022-02-21
A-C
Hebei Medical University
Phase 2/3 Completed
NCT03093870 2021-08-03
TreeTopp
ASLAN Pharmaceuticals
Phase 2/3 Completed
NCT00212615 2020-11-06
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
Odense University Hospital
Phase 2/3 Completed
NCT00418028 2019-02-22
Standard Versus Continuous Capecitabine in Advanced Breast Cancer
Hospital San Carlos, Madrid
Phase 2/3 Completed
NCT01204437 2016-02-10
ICE-II
GBG Forschungs GmbH
Phase 2/3 Completed
NCT00960284 2012-01-13
PACT-7
IRCCS San Raffaele
Phase 2/3 Completed
NCT00201435 2008-05-20
Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC
Norwegian Breast Cancer Group
Phase 2/3 Completed
NCT00294359 2007-08-22
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group
Phase 2/3 Completed